These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7827358)

  • 1. Effects of non-esterified fatty acids on insulin-stimulated glucose transport in isolated skeletal muscle from patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Galuska D; Nolte L; Wahlström E; Smedegaard Kristensen JS; Wallberg-Henriksson H; Zierath JR
    Acta Diabetol; 1994 Sep; 31(3):169-72. PubMed ID: 7827358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.
    Zierath JR; Galuska D; Nolte LA; Thörne A; Kristensen JS; Wallberg-Henriksson H
    Diabetologia; 1994 Mar; 37(3):270-7. PubMed ID: 8174841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.
    Zierath JR; Handberg A; Tally M; Wallberg-Henriksson H
    Diabetologia; 1996 Mar; 39(3):306-13. PubMed ID: 8721776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle.
    Nolte LA; Galuska D; Martin IK; Zierath JR; Wallberg-Henriksson H
    Acta Physiol Scand; 1994 May; 151(1):51-9. PubMed ID: 8048336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK; Wi JK; Youn JH
    Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM.
    Galuska D; Nolte LA; Zierath JR; Wallberg-Henriksson H
    Diabetologia; 1994 Aug; 37(8):826-32. PubMed ID: 7988785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
    Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
    Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
    Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
    Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased insulin-stimulated 3-0-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects.
    Andréasson K; Galuska D; Thörne A; Sonnenfeld T; Wallberg-Henriksson H
    Acta Physiol Scand; 1991 Jun; 142(2):255-60. PubMed ID: 1877373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
    Kelley DE; Simoneau JA
    J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of decreased insulin-induced glucose transport in skeletal muscle of glucose-intolerant hybrids of diabetic GK rats.
    Nolte LA; Abdel-Halim SM; Martin IK; Guenifi A; Zierath JR; Ostenson CG; Wallberg-Henriksson H
    Clin Sci (Lond); 1995 Mar; 88(3):301-6. PubMed ID: 7736698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.
    Dohm GL; Tapscott EB; Pories WJ; Dabbs DJ; Flickinger EG; Meelheim D; Fushiki T; Atkinson SM; Elton CW; Caro JF
    J Clin Invest; 1988 Aug; 82(2):486-94. PubMed ID: 3403714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
    Björnholm M; Kawano Y; Lehtihet M; Zierath JR
    Diabetes; 1997 Mar; 46(3):524-7. PubMed ID: 9032113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia activates glucose transport in rat skeletal muscle via a Ca(2+)-dependent mechanism.
    Nolte LA; Rincón J; Wahlström EO; Craig BW; Zierath JR; Wallberg-Henriksson H
    Diabetes; 1995 Nov; 44(11):1345-8. PubMed ID: 7589835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin action on glucose transport in isolated skeletal muscle from patients with liver cirrhosis.
    Johansson U; Eriksson LS; Galuska D; Zierath JR; Wallberg-Henriksson H
    Scand J Gastroenterol; 1994 Jan; 29(1):71-6. PubMed ID: 8128180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips.
    Zierath JR; Galuska D; Engström A; Johnson KH; Betsholtz C; Westermark P; Wallberg-Henriksson H
    Diabetologia; 1992 Jan; 35(1):26-31. PubMed ID: 1541378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of exercise and insulin in type II diabetes mellitus.
    Wallberg-Henriksson H
    Diabetes Care; 1992 Nov; 15(11):1777-82. PubMed ID: 1468314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus.
    Scarlett JA; Kolterman OG; Ciaraldi TP; Kao M; Olefsky JM
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1195-201. PubMed ID: 6341390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.
    Saloranta C; Franssila-Kallunki A; Ekstrand A; Taskinen MR; Groop L
    Diabetologia; 1991 Jun; 34(6):409-15. PubMed ID: 1884899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.